Skip to Main Content

Paper Details

LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.
Proc Natl Acad Sci U S A
140
2018
AR, LSD1, LSD1's binding protein, Lysine, Lysine-specific demethylase 1, SP-2509, ZNF217, advanced prostate cancer, androgen, androgen receptor, castration-resistant, castration-resistant prostate, histone demethylase, prostate, prostate cancer, prostate cancer cells, prostate cancer gene network, tumors
Cell Survival, Gene Regulatory Networks, Histone Demethylases, Humans, Hydrazines, Male, Neoplasm Proteins, Prostatic Neoplasms, Castration-Resistant, Sulfonamides, Trans-Activators
Author NameAffiliation
Archana SehrawatKnight Cancer Institute, Oregon Health & Science University
Lina GaoKnight Cancer Institute, Oregon Health & Science University
Yuliang WangOregon Health & Science University
Yuliang WangOregon Health & Science University
Armand BankheadUniversity of Michigan ann arbor
Shannon K McWeeneyKnight Cancer Institute, Oregon Health & Science University
Shannon K McWeeneyMedical Informatics and Clinical Epidemiology, Oregon Health & Science University
Carly J KingOregon Health & Science University
Jacob SchwartzmanKnight Cancer Institute, Oregon Health & Science University
Joshua UrrutiaKnight Cancer Institute, Oregon Health & Science University
William H BissonOregon State University
Daniel J ColemanKnight Cancer Institute, Oregon Health & Science University
Sunil K JoshiKnight Cancer Institute, Oregon Health & Science University
Dae Hwan KimKnight Cancer Institute, Oregon Health & Science University
David SampsonKnight Cancer Institute, Oregon Health & Science University
Sheila WeinmannCenter for Health Research, Kaiser Permanente NW
Bhaskar KallakuryMedstar Georgetown University Hospital
Deborah L BerryLombardi Comprehensive Cancer Center, Georgetown University Medical Center
Reina HaqueKaiser Permanente
Stephen K Van Den EedenKaiser Permanente Northern California
Sunil SharmaHuntsman Cancer Institute, University of Utah
Jared BearssHuntsman Cancer Institute, University of Utah
Tomasz M BeerKnight Cancer Institute, Oregon Health & Science University
Thomas J GeorgeKnight Cancer Institute, Oregon Health & Science University
Thomas J GeorgeOregon Health & Science University
Laura M HeiserOregon Health & Science University
Laura M HeiserOregon Health & Science University
Joshi J AlumkalKnight Cancer Institute, Oregon Health & Science University
  • 1 - 28

Datasets

Release 1.2